SCHEMBL135052

SCHEMBL135052

Cc1ccc2oc(S)nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.58
KDM4E B2RXH2 10/20 0.58
NPC1 O15118 9/20 0.58
ALDH1A1 P00352 9/20 0.58
HPGD P15428 8/20 0.58
SMN1; SMN2 Q16637 8/20 0.58
HSD17B10 Q99714 6/20 0.58
TP53 P04637 4/20 0.58
CASP3 P42574 3/20 0.54
SENP7 Q9BQF6 3/20 0.54
SENP6 Q9GZR1 3/20 0.54
SENP8 Q96LD8 2/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 6/20 0.50
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
NFKB1 P19838 5/20 0.49
NFKB2 Q00653 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29593199 1.00 RAB9A (0.58) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL28874458 0.85 ALDH1A1 (0.56) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL2538594 0.84 KDM4E (0.59) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL28874293 0.81 L3MBTL1 (0.54) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL29878660 0.81 L3MBTL1 (0.54) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL9105844 0.79 NPC1 (0.61) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL29442076 0.79 NPC1 (0.61) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL903255 0.79 NPC1 (0.61) RAB9AKDM4ENPC1ALDH1A1HPGD
Iodide SCHEMBL8417295 0.78 NPC1 (0.59) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL4454889 0.76 MPO (0.45) KDM4EMAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120059421-A High-strength regenerated PET composite material and preparation method thereof 江西绿聚科技有限公司 2025-05-30 CN claimed
CN-115703737-A Hydroxypyridones compounds and application thereof as antibiotic sensitizer for overcoming drug resistance of bacterial biofilm 暨南大学 2023-02-17 CN claimed
EP-3686203-A1 4-SULFUR SUBSTITUTED PODOPHYLLOTOXIN DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF Tang, Yajie (CN) 2020-07-29 EP claimed
CN-111454308-A Teniposide derivative and preparation method and application thereof 湖北工业大学 2020-07-28 CN claimed
US-20200216462-A1 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof Tang, YaJie (CN) 2020-07-09 US claimed
US-20200216449-A1 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof Tang, YaJie (CN) 2020-07-09 US claimed
CN-108285456-A 4- sulphur replaces podophyllotoxin derivative and its preparation method and application 汤亚杰 2018-07-17 CN claimed
CN-120059421-A High-strength regenerated PET composite material and preparation method thereof 江西绿聚科技有限公司 2025-05-30 CN disclosed
US-20250051319-A1 COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS AUGUSTINE THERAPEUTICS (BE) 2025-02-13 US disclosed
US-20240409533-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2024-12-12 US disclosed
CN-115703737-B Hydroxypyridones compound and application thereof as antibiotic sensitizer for overcoming bacterial biomembrane resistance 暨南大学 2024-09-24 CN disclosed
US-12071433-B2 HMOX1 inducers Astellas Engineered Small Molecules US, Incorporated (US) 2024-08-27 US disclosed
CN-117843579-A Benzo heterocycle coupled catechol derivative and preparation method and application thereof 暨南大学 2024-04-09 CN disclosed
US-5124235-A Photopolymerization initiator and photosensitive composition employing the same CANON KABUSHIKI KAISHA (JP) 1992-06-23 US disclosed
EP-0453317-A2 Image forming medium CANON KABUSHIKI KAISHA (JP) 1991-10-23 EP disclosed
EP-0353030-A2 Photopolymerization initiator and photosensitive composition employing the same CANON KABUSHIKI KAISHA (JP) 1990-01-31 EP disclosed
EP-0087701-B1 PROCESS FOR THE PREPARATION OF 2-CHLOROBENZOXAZOLS CASSELLA Aktiengesellschaft (DE) 1986-08-20 EP disclosed
US-4517370-A Process for preparing 2-chlorobenzoxazoles CASSELLA AKTIENGESELLSCHAFT (DE) 1985-05-14 US disclosed
EP-0129506-A2 Heterocyclically substituted thio(cyclo)alkane polycarboxylic acids CIBA-GEIGY AG (CH) 1984-12-27 EP disclosed
EP-0087701-A2 Process for the preparation of 2-chlorobenzoxazols CASSELLA Aktiengesellschaft (DE) 1983-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051319-A1 COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS HDAC6, HDAC9, HDAC1 RAB9A 75/4885KDM4E 2750/4885NPC1 620/4885
US-20200216462-A1 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof WEE1, WEE2, DHFR RAB9A 3952/4885KDM4E 1474/4885NPC1 4632/4885
US-20200216449-A1 4-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof TPMT, WEE1, DHFR RAB9A 4217/4885KDM4E 200/4885NPC1 4717/4885
US-20240409533-A1 HMOX1 INDUCERS HMOX1, HMOX2, HMBS RAB9A 4748/4885KDM4E 2510/4885NPC1 3451/4885
US-12071433-B2 HMOX1 inducers HMOX1, HMOX2, HMBS RAB9A 4725/4885KDM4E 2606/4885NPC1 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.